Helicos Files for $100 Million IPO

Helicos Biosciences Corp., a Cambridge, Mass.-based DNA sequencing company, has filed for a $100 million IPO. It plans to trade on the Nasdaq under ticker symbol HLCS, with UBS serving as lead underwriter. The company has raised around $67 million in VC funding from firms like Flagship Ventures, Atlas Venture, Highland Capital Partners, MPM Capital and Versant Ventures. www.helicosbio.com